Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • simonandrews
    Simon Andrews
    • May 2009
    • 870

    Bioinfo-core conference call on ChIP-Seq

    The Bioinfo-core group are a collection of people working for bioinformatics core facilities around the world. The aim of the group is to share experience between members of the group and to provide a forum where the community of core facilities can have a voice.

    In addition to a yearly workshop at ISMB the group also arrange a series of conference calls on relevant informatics topics. These are open to anyone who is interested and we encourage as many people as possible to attend.

    The next conference call for the group is today at 11AM ET (8AM PT, 5PM CET, 4PM BST). The reason for posting this here is that the major topic for discussion is how best to deal with ChIP Seq data. There should be a range of experience from different core facilities, but we welcome anyone with an interest in this area to come along.

    To join the call you can call one of the toll free numbers on this list and use the access code 6430305.

    We would encourage anyone who has a general interest in core facilities to join our mailing list where the bulk of the activity of our group happens throughout the year.
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Hey Simon,

    I'd encourage you to consider consolidating your group here...maybe I'm being a bit oversensitive, but it's not typically polite to recruit for alternate web communities within a given community. If you need a specific forum or other support from this site, let me know. I'm sure the entire worldwide community would benefit from your discussions.

    I've subscribed to your mailing list...looking forward to participating in your discussions.

    Thanks!

    -=Eric

    Comment

    • ECO
      --Site Admin--
      • Oct 2007
      • 1360

      #3
      Me again...to be proactive about this...I just activated a Core Facilities forum in case you would like to bring your discussions here.

      Comment

      • simonandrews
        Simon Andrews
        • May 2009
        • 870

        #4
        Eric,

        Sorry if you thought my post was inappropriate. I'd quite understand if you choose to remove it as an administrator. I hoped I wouldn't be stepping on anyone's toes since there is generally very little overlap between Bioinfo-core and Seqanswers. Generally bioinfo-core is focussed on the running of core facilities, which covers everything from recruitment to charging models and all aspects of informatics (of which sequencing is just one part).

        It just so happened that this one conference call involved next gen sequencing - hence my thought that it may interest people here. All of our calls are written up and published on our wiki so I'd be happy to post the summary here afterwards for further discussion.

        Simon.

        Comment

        • ECO
          --Site Admin--
          • Oct 2007
          • 1360

          #5
          No worries Simon, as I said it's late here and I may be oversensitive. I've done my best to never remove a post here (spam excluded).

          Of course you're welcome to handle things as you see appropriate, I was just thinking that the challenges of a core facility (both wet-bench and bioinformatic) could be extremely informative to the wider community. Many of the questions we get here (particularly data storage, cluster size, pipelines...etc) have been extensively researched and "answered" by many different core facilities around the world. But believe me, I understand that this information could be thought of as a competitive advantage...so many groups would want to keep it confidential.

          Please feel free to continue to post anything even remotely related to next gen data...I'm just content that you've identified the site as useful.

          sleepily,
          -=eric

          Comment

          • ECO
            --Site Admin--
            • Oct 2007
            • 1360

            #6
            I guess my hope of learning from that mailing list was dashed...

            Your request to the bioinfo-core mailing list

            Subscription request

            has been rejected by the list moderator. The moderator gave the
            following reason for rejecting your request:

            "Service accounts not acceptable, named academic or non-commercial
            oriented members only."

            Any questions or comments should be directed to the list administrator
            at:

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            28 views
            0 reactions
            Last Post SEQadmin2  
            Working...